Percutaneous ablative treatments of hepatocellular carcinoma
Gian Ludovico Rapaccini – 21 November 2014
Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune‐suppressing and anticancer drugs: Just the tip of the iceberg?
Adrian M. Bisceglie, Anna S. Lok, Paul Martin, Norah Terrault, Robert P. Perrillo, Jay H. Hoofnagle – 21 November 2014 – Reactivation of hepatitis B in the context of immunosuppressive therapy may be severe and potentially fatal. The US Food and Drug Administration has recently drawn attention to the potentially fatal risk of hepatitis B reactivation in patients receiving the anti‐CD20 agents ofatumumab or rituximab.
Cardiac tamponade following liver transplantation after intrapericardial control of the suprahepatic vena cava
Junming Xu, Johnny C. Hong, Ronald W. Busuttil – 19 November 2014 – Transabdominal intrapericardial control of the suprahepatic inferior vena cava (SIVC) is a rather uncommon procedure occasionally required in conjunction with complicated liver transplantation (LT) and hepatobiliary surgery. Experience with this technique is limited. Here we report 6 cases of LT in which transabdominal intrapericardial control of the SIVC was necessary.
Transarterial chemoembolization and radiological vascular complications
Fabrizio Panaro, Boris Guiu, Francis Navarro – 19 November 2014
The case for cost‐effectively treating cryoglobulinemic vasculitis with interferon‐free anti–hepatitis C virus therapy
Marcella Visentini, Stefania Colantuono, Guido Granata, Adriano de Santis, Massimo Fiorilli, Milvia Casato – 7 November 2014
Transforming growth factor‐β–induced long noncoding RNA promotes liver cancer metastasis via RNA–RNA crosstalk
Tingting Sun, Nathalie Wong – 7 November 2014
Should patients with hepatitis C genotype 2/3 infection who are slow responders to pegylated interferon/ribavirin have treatment duration extended?
Carla Silva, Elizabeth Ianna, Tracey Jones, Joshua S. Davis – 7 November 2014
National survey of adult transplant hepatologists on the pediatric‐to‐adult care transition after liver transplantation
Madeleine R. Heldman, Min‐Woong Sohn, Elisa J. Gordon, Zeeshan Butt, Saeed Mohammed, Estella M. Alonso, Josh Levitsky – 6 November 2014 – Adult transplant hepatologists face challenges in providing care to young adults who received liver transplants during childhood. Because prior studies have focused mainly on pediatric providers, understanding these issues from the perspective of the adult hepatologist may provide novel insights and identify key barriers to care in this population.
Is the Molecular Adsorbent Recirculating System the Answer for Children With Acute Liver Failure?
Philip Rosenthal – 6 November 2014
Hepatic artery stenosis after liver transplantation: Is endovascular treatment always necessary?
Carlo Pulitano, David Joseph, Charbel Sandroussi, Deborah Verran, Simone I. Strasser, Nicholas A. Shackel, Geoffrey W. McCaughan, Michael Crawford – 6 November 2014 – Hepatic artery stenosis (HAS) is thought to predispose patients to biliary complications secondary to ischemic injury. Despite this, the clinical significance of HAS remains poorly defined. The aims of this study were to determine the prevalence and outcomes of HAS and to define which patients might benefit from endovascular treatment.